Serum Levels of the Th1 Promoter IL-12 and the Th2 Chemokine TARC Are Elevated in Erythema Multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Correlate with Soluble Fas Ligand Expression
Serum Levels of the Th1 Promoter IL-12 and the Th2 Chemokine TARC Are Elevated in Erythema Multiforme and Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Correlate with Soluble Fas Ligand Expression
复制标题
多形红斑和 Stevens-Johnson 综合征/中毒性表皮坏死松解症中 Th1 启动子 IL-12 和 Th2 趋化因子 TARC 的血清水平升高,并与可溶性 Fas 配体表达相关
作者:
P. Quaglino;M. Caproni;E. Antiga;E. del Bianco;S. Osella;P. Savoia;A. Frezzolini;D. Schena;A. Marzano;W. Volpi;C. De Simone;A. Parodi;P. Fabbri;M. Bernengo
Background: No data exist as to Th2 chemokines in erythema multiforme (EM) and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). Objective: To evaluate thymus- and activation-regulated chemokine (TARC), macrophage-derived chemokine (MDC) and regulated upon activation, normal T-lymphocyte-expressed and secreted chemokine (RANTES) expression in EM and SJS/TEN and to correlate with the serum levels of the Th1 promoter interleukin (IL)-12 and soluble Fas ligand (sFasL). Materials and Methods: IL-12, sFasL, TARC, MDC and RANTES expression were analyzed by ELISA techniques in 31 untreated EM (n = 24) or SJS/TEN (n = 7) patients and in 28 healthy donors (HD). Results: EM and SJS/TEN exhibited significantly higher levels of TARC, IL-12 and sFasL with respect to HD. TARC upregulation paralleled both the IL-12 (p = 0.0225) and sFasL increase (p = 0.0194). Conclusions: Our results support a role of TARC in the pathophysiology of EM/SJS/TEN and confirm the coexistence of a Th2 response in addition to the predominant Th1 profile.
DOI:
--
发表时间:
2003
期刊:
Dermatology online journal [electronic resource].
影响因子:
--
作者:
Aurelian,L;Ono,F;Burnett,J
通讯作者:
Burnett,J
影响因子:
3.8
作者:
H. Fan;C. Walters;G. Dunston;R. Tackey
通讯作者:
H. Fan;C. Walters;G. Dunston;R. Tackey